POLUS BioPharm Inc. (KOSE:A007630) announced a private placement of 27th series unregistered coupon unguaranteed unsecured collateral private convertible bonds for gross proceeds of KRW 20,000,000,000 on March 14, 2018. The transaction will include participation from existing investor KB Securities Co., Ltd., Investment Arm. The bond carries a coupon rate of 4% per annum and yield to maturity is 4% will mature on April 10, 2023. The bonds will be fully convertible into 1,267,266 shares at a fixed conversion price of KRW 15,782 per share between April 10, 2019 and March 10, 2023. The transaction is expected to close on April 10, 2018.